Suppr超能文献

阿替洛尔对血浆高密度脂蛋白胆固醇亚组分的影响。

Effect of atenolol on plasma HDL cholesterol subfractions.

作者信息

Lehtonen A, Marniemi J

出版信息

Atherosclerosis. 1984 May-Jun;51(2-3):335-8. doi: 10.1016/0021-9150(84)90181-3.

Abstract

The effect of atenolol on plasma HDL cholesterol subfractions and other plasma lipids in 18 patients with essential hypertension was studied. The atenolol was given orally, in a dose of 100 mg once daily for 6 months. The level of HDL cholesterol during atenolol treatment was significantly lower than before it. The concentration of HDL2 cholesterol decreased (P less than 0.01) during the first month of therapy and remained constant during treatment. The level of HDL3 cholesterol decreased slightly but not significantly. The concentrations of plasma triglycerides and total cholesterol increased slightly during atenolol treatment; statistical significance was reached (P less than 0.05) at 6 months.

摘要

研究了阿替洛尔对18例原发性高血压患者血浆高密度脂蛋白胆固醇亚组分及其他血脂的影响。阿替洛尔口服给药,剂量为每日100毫克,持续6个月。阿替洛尔治疗期间高密度脂蛋白胆固醇水平显著低于治疗前。治疗第一个月高密度脂蛋白2胆固醇浓度下降(P<0.01),治疗期间保持稳定。高密度脂蛋白3胆固醇水平略有下降,但无显著差异。阿替洛尔治疗期间血浆甘油三酯和总胆固醇浓度略有升高;6个月时达到统计学显著性(P<0.05)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验